COMPASS Pathways Plc (CMPS)
Factsheet
-
Market Capitalisation
$360 Mln
-
-
Price to Earnings Ratio
--
-
12 Month Earnings
$-39 Mln
COMPASS Pathways Plc (CMPS) Share Price
NASDAQ
$6.10
As on 04-Dec-2023 16:00 EST
$0.00
•
0.00%
As on 04-Dec-2023 16:00 EST
-
Prev Close
$6.10
-
Day's Open
$6.03
-
Today's High
$6.28
-
Today's Low
$5.74
-
Today's Volume
473,760
-
52 Week range
$5.01 - 11.48
Please wait...
COMPASS Pathways Plc (CMPS) Stock Performance
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
COMPASS Pathways (CMPS)
| -24.03 | -4.84 | -34.62 | -45.58 | -51.50 | -- | -- |
|
S&P BSE Sensex*
| 13.75 | 7.53 | 5.46 | 10.08 | 15.36 | 13.88 | 12.82 |
|
S&P BSE Healthcare#
| 32.48 | 9.92 | 9.75 | 27.53 | 13.31 | 16.60 | 12.24 |
As on 04-Dec-2023
| *As on 05-Dec-2023 | #As on 05-Dec-2023
|
2022
|
2021
|
|
|---|---|---|
|
COMPASS Pathways (CMPS)
| -63.67 | -53.61 |
|
S&P BSE Sensex
| 4.44 | 21.99 |
|
S&P BSE Healthcare
| -12.10 | 20.87 |
Valuation
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Growth & Efficiency
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Solvency
Is there a threat to this company's solvency in the future?
Financial Manipulation
Can creative accounting be detected through the financial numbers?
COMPASS Pathways Plc (CMPS) Peer Comparison
Please wait...
Valuation Chart of COMPASS Pathways Plc (CMPS)
Please wait...
Please wait...
Financials
Please wait...
Please wait...
Please wait...
Shareholding Pattern
Other details of COMPASS Pathways Plc (CMPS)
Exec. Chairman & Co-Founder
Mr. George Jay Goldsmith
Co-Founder, Chief Innovation Officer & Exec. Director
Dr. Ekaterina Malievskaia M.D.
Headquarters
LondonWebsite
https://compasspathways.comFAQs for COMPASS Pathways Plc (CMPS)
What is the total asset value of COMPASS Pathways Plc (CMPS)?
The total asset value of COMPASS Pathways Plc (CMPS) stood at $ 185 Mln as on 31-Mar-23
What is the current share price of COMPASS Pathways Plc (CMPS)?
The share price of COMPASS Pathways Plc (CMPS) is $6.10 (NASDAQ) as of 04-Dec-2023 16:00 EST. COMPASS Pathways Plc (CMPS) has given a return of -51.5% in the last 3 years.
What is the market cap of COMPASS Pathways Plc (CMPS)?
COMPASS Pathways Plc (CMPS) has a market capitalisation of $ 360 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.
What is the current PB ratio of COMPASS Pathways Plc (CMPS)?
The P/B ratio of COMPASS Pathways Plc (CMPS) is 2.18 times as on 02-Jun-2023, a -0.18% premium to its peers’ median range of 2.67 times.
What is the current P/E ratio of COMPASS Pathways Plc (CMPS)?
Since, TTM earnings of COMPASS Pathways Plc (CMPS) is negative, P/E ratio is not available.
How can you buy shares of COMPASS Pathways Plc (CMPS)?
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the COMPASS Pathways Plc (CMPS) and enter the required number of quantities and click on buy to purchase the shares of COMPASS Pathways Plc (CMPS).
What is the main business of COMPASS Pathways Plc (CMPS)?
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Who are the promoters/managers of COMPASS Pathways Plc (CMPS)?
The CEO & director of Mr. George Jay Goldsmith. is COMPASS Pathways Plc (CMPS), and CFO & Sr. VP is Dr. Ekaterina Malievskaia M.D..
What is the total promoter pledging in COMPASS Pathways Plc (CMPS)?
The promoters of COMPASS Pathways Plc (CMPS) have pledged 0% of the total equity as on Mar-23.
Who are the competitors of COMPASS Pathways Plc (CMPS)?
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
330
|
|
|
161
|
|
|
116
|
|
|
79
|
What are the key ratios of COMPASS Pathways Plc (CMPS)?
| COMPASS Pathways Plc (CMPS) | Ratios |
|---|---|
|
Return on equity(%)
|
-53.08
|
|
Return on capital employed(%)
|
--
|
|
Debt-to-equity ratio
|
0
|
|
Dividend yield(%)
|
0
|
Is the COMPASS Pathways Plc (CMPS) profitable?
No, TTM profit after tax of COMPASS Pathways Plc (CMPS) was $-39 Mln.
Edit
Please wait...
Please wait...
Key Facts
-
Market cap
$359.50 Mln
-
Revenue (TTM)
$0.00 Mln
-
Earnings (TTM)
$-39.41 Mln
-
Cash
$117.10 Mln
-
Total Debt
$1.52 Mln
- Insider's Holding 45.43%
-
Liquidity
High
-
52 Week range
$5.01 - 11.48
-
Shares outstanding
45,621,700
-
5 Years Aggregate:
CFO: $-242.19 Mln
EBITDA: $-239.39 Mln
Net Profit: $-256.41 Mln
About The Company
- IPO Date 18-Sep-2020
- Exec. Chairman & Co-Founder Mr. George Jay Goldsmith
- Co-Founder, Chief Innovation Officer & Exec. Director Dr. Ekaterina Malievskaia M.D.
-
Listing
NASDAQ: CMPS
- Country United Kingdom
-
Headquarters
London
-
Website
https://compasspathways.com
-
Business
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression;... and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom. Read more
